Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma | Zendy

Mario Castro | Zendy; Jonathan Corren | Zendy; Ian Pavord | Zendy; Jorge Máspero | Zendy; Sally E. Wenzel | Zendy; Klaus F. Rabe | Zendy; William W. Busse | Zendy; Linda Ford | Zendy; Lawrence Sher | Zendy; J. Mark FitzGerald | Zendy; Constance H. Katelaris | Zendy; Yuji Tohda | Zendy; Bingzhi Zhang | Zendy; Heribert Staudinger | Zendy; Gianluca Pirozzi | Zendy; Nikhil Amin | Zendy; Marcella Ruddy | Zendy; Bolanle Akinlade | Zendy; Asif Khan | Zendy; Jingdong Chao | Zendy; Renata Martincova | Zendy; Neil M.H. Graham | Zendy; Jennifer D. Hamilton | Zendy; Brian N. Swanson | Zendy; Neil Stahl | Zendy; George D. Yancopoulos | Zendy; Ariel Teper | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

Author(s) -

Mario Castro,

Jonathan Corren,

Ian Pavord,

Jorge Máspero,

Sally E. Wenzel,

Klaus F. Rabe,

William W. Busse,

Linda Ford,

Lawrence Sher,

J. Mark FitzGerald,

Constance H. Katelaris,

Yuji Tohda,

Bingzhi Zhang,

Heribert Staudinger,

Gianluca Pirozzi,

Nikhil Amin,

Marcella Ruddy,

Bolanle Akinlade,

Asif Khan,

Jingdong Chao,

Renata Martincova,

Neil M.H. Graham,

Jennifer D. Hamilton,

Brian N. Swanson,

Neil Stahl,

George D. Yancopoulos,

Ariel Teper

Publication year - 2018

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1804092

Subject(s) - dupilumab , medicine , asthma , monoclonal antibody , monoclonal , clinical efficacy , interleukin , immunology , antibody , cytokine

Dupilumab is a fully human anti-interleukin-4 receptor α monoclonal antibody that blocks both interleukin-4 and interleukin-13 signaling. We assessed its efficacy and safety in patients with uncontrolled asthma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore